LIOFILCHEM SRL 75009U ComASP

MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Ceftolozane/Tazobactam 0.016/4 – 256/4 μg/mL are specialized strips impregnated with a predefined concentration gradient of ceftolozane/tazobactam for susceptibility testing of Enterobacter cloacae, E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa

The Liofilchem® MTS™ (MIC Test Strip) is a quantitative method intended for the in vitro determination ofantimicrobial susceptibility ofbacteria MTS™ consists ofspecialized papyr impregnated with a pre-defined concentration gradient ofan antimicrobial agent, which is used todetermine the minimum inhibitozy concentration (MIC) in µglmL ofantimicrobial agents against bacteria as tested on agar media using ovemightincubation and manual reading procedures. The MTS™ Plazomicin at concentrations of0.016-256 µglmL should be interpreted at 16-20 hours ofincubation.MTS™ PLZ can be used to dete1mine the MIC ofplazomicin against the microorganisms listed below:Plazomicin Activity According to the FDA LabelClinical and in vitroEnterobacter cloacaeEscherichia coliKlebsiella pneumoniaeProteus mirabilisin vitro onlyCitrobacterfreundiiCitrobacter koseriKlebsiella (Enterobacter) aerogenesKlebsiella oxytocaMorganella morganiiProteus vulgarisProvidencia stuartiiSerratia marcescens

MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Linezolid 0.016 – 256 μg/mL are specialized strips impregnated with a predefined concentration gradient of Linezolid for susceptibility testing of Staphylococcus aureus (including methicillin-resistant isolates), Enterococcus faecium (vancomycin resistant isolates only).

MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Erythromycin 0.016 - 256μg/m are specialized strips impregnated with a predefined concentration gradient of Erythromycin for susceptibility testing of Staphylococcus aureus.

MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Vancomycin 0.016-256 μg/mL are specialized strips impregnated with a predefined concentration gradient of vancomycin for susceptibility testing of nonfastidious species, Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis and Enterococcus faecium.

MIC Tests Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Ceftazidime-avibactam 0.016/4 – 256 /4 µg/mL are specialized strips impregnated with a predefined concentration gradient of Ceftazidime and Avibactam for susceptibility testing of Citrobacter freundii, Enterobacter cloacae, Escherichia Coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis and Pseudomonas aeruginosa.

MIC Test Strip is a quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) of antimicrobial agents against microorganisms. Liofilchem MIC Test Strip Ceftolozane/Tazobactam 0.016/4 – 256/4 μg/mL are specialized strips impregnated with a predefined concentration gradient of ceftolozane/tazobactam for susceptibility testing of Enterobacter cloacae, E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa

The Liofilchem® MTS™ (MIC Test Strip) is a quantitative method intended for the in vitro determination ofantimicrobial susceptibility ofbacteria MTS™ consists ofspecialized papyr impregnated with a pre-defined concentration gradient ofan antimicrobial agent, which is used todetermine the minimum inhibitozy concentration (MIC) in µglmL ofantimicrobial agents against bacteria as tested on agar media using ovemightincubation and manual reading procedures. The MTS™ Plazomicin at concentrations of0.016-256 µglmL should be interpreted at 16-20 hours ofincubation.MTS™ PLZ can be used to dete1mine the MIC ofplazomicin against the microorganisms listed below:Plazomicin Activity According to the FDA LabelClinical and in vitroEnterobacter cloacaeEscherichia coliKlebsiella pneumoniaeProteus mirabilisin vitro onlyCitrobacterfreundiiCitrobacter koseriKlebsiella (Enterobacter) aerogenesKlebsiella oxytocaMorganella morganiiProteus vulgarisProvidencia stuartiiSerratia marcescens